Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2408)
All Articles published online
|
Nov 27, 2010 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Suzuki H, Kakizaki S, Horiguchi N, Ichikawa T, Sato K, Takagi H, Mori M. Clinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis C. World J Hepatol 2010; 2(11): 401-405 [PMID: 21173908 DOI: 10.4254/wjh.v2.i11.401] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v2/i11/401.htm |
| Number | Citing Articles |
| 1 |
Yuki Wada, Hideyuki Tamai, Akira Kawashima, Naoki Shingaki, Yoshiyuki Mori, Masanori Kawaguchi, Kosaku Moribata, Hisanobu Deguchi, Kazuki Ueda, Izumi Inoue, Takao Maekita, Mikitaka Iguchi, Jun Kato, Masao Ichinose. Prediction of a Null Response to Pegylated Interferon α-2b Plus Ribavirin in Patients with High Viral Load Genotype 1b Hepatitis C. Gut and Liver 2014; 8(4): 421 doi: 10.5009/gnl.2014.8.4.421
|
| 2 |
Nicholas A. Meanwell, Ramkumar Rajamani, Paul M. Scola,
Li-Qiang Sun. HCV: The Journey from Discovery to a Cure. Topics in Medicinal Chemistry 2019; 31: 317 doi: 10.1007/7355_2018_58
|
| 3 |
Mehmet Bayram, Ali Riza Koksal, Huseyin Alkim, Salih Boga, Meltem Ergun, Osman Ozdogan, Engin Altinkaya, Canan Alkim. First Week HCV RNA Level Under the Pegylated Interferon and Ribavirin Treatment Predicts Sustained Virological Response. American Journal of Therapeutics 2016; 23(6): e1612 doi: 10.1097/MJT.0000000000000279
|
| 4 |
Masashi Namikawa, Satoru Kakizaki, Yutaka Yata, Yuichi Yamazaki, Norio Horiguchi, Ken Sato, Hitoshi Takagi, Masatomo Mori. Optimal follow‐up time to determine the sustained virological response in patients with chronic hepatitis C receiving pegylated‐interferon and ribavirin. Journal of Gastroenterology and Hepatology 2012; 27(1): 69 doi: 10.1111/j.1440-1746.2011.06802.x
|